Definitely not. Wait for the next quarterly report. They will need to raise. This is Australia mate. Nothing gets done in December. They only go commercial once clinical studies are validated. Lots of risk here. NFA DYOR. February 2025 would be best case scenario for commercial launch. Keeping it on the Watch list.
Ann: Company Presentation - Investor Insights, page-10
-
- There are more pages in this discussion • 77 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BDX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
11.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $41.08M | |||
| Open | High | Low | Value | Volume |
| 11.5¢ | 11.8¢ | 11.5¢ | $37.22K | 323.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 441799 | 11.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 11.5¢ | 66889 | 1 |
View Market Depth
| Last trade - 15.18pm 26/07/2024 (20 minute delay) ? |
| BDX (ASX) Chart |